Tag Archives: STL Medical News

Opioids Posing Increasingly Dangerous Threats to Emergency Nurses

Strategies to combat the crisis will be a focus at the Emergency Nurses Association’s upcoming national conference DES PLAINES, IL/July 21, 2017 (STL.News) – The opioid epidemic ravaging communities across the United States is posing a new threat to those on the front line who are working to combat it. Increasingly, police officers, paramedics and … Continue reading Opioids Posing Increasingly Dangerous Threats to Emergency Nurses

Simmons Hanly Conroy Files Lawsuit for New York’s Schenectady County against Drug Companies over Opioid Epidemic and Addiction

Similar lawsuits also pending on behalf of New York’s Broome, Erie, Dutchess, Orange, Seneca, Suffolk and Sullivan counties NEW YORK/June 15, 2017 (STL.News) – Simmons Hanly Conroy, one of the nation’s largest law firms focused on consumer protection and mass tort actions, has filed a lawsuit on behalf of New York’s Schenectady County against pharmaceutical … Continue reading Simmons Hanly Conroy Files Lawsuit for New York’s Schenectady County against Drug Companies over Opioid Epidemic and Addiction

Senate Advances Measure with Strongest Protections for Innocent Unborn Children in Years

The Bill Will Also Help Ensure the Health and Safety of Women In Missouri JEFFERSON CITY, MO/June 15, 2017 (STL.News) — The Senate advanced a measure this week that closes loopholes in Missouri’s abortion laws and further protects First Amendment rights. During the Second Extraordinary Session of the 99th General Assembly, the Legislature was called … Continue reading Senate Advances Measure with Strongest Protections for Innocent Unborn Children in Years

Glucagon-Blocking Drug Reduces Need for Insulin and Improves Blood Glucose Levels for Patients with Type 1 Diabetes

SAN DIEGO, CA/June 13, 2017 (STL.News) – A single dose of the glucagon-blocking drug REMD-477 can substantially reduce the amount of insulin needed and improve glucose levels without increasing hypoglycemia (low blood glucose levels) in patients with type 1 diabetes, according to the study, “REMD-477, a Human Glucagon Receptor (GCGR) Antibody, Reduces Daily Insulin Requirements … Continue reading Glucagon-Blocking Drug Reduces Need for Insulin and Improves Blood Glucose Levels for Patients with Type 1 Diabetes

Top RN to BSN Releases 50 Best Online RN to BSN Programs 2017

RALEIGH, NC/June 12, 2017 (STL.News) – Top RN to BSN (http://www.toprntobsn.com), an independent online guide to the best higher education and career options for current and prospective nurses, is pleased to share their 50 Best Online RN to BSN Programs 2017 at http://www.toprntobsn.com/best-rn-to-bsn-online/. With the demands of contemporary nursing–some due to an aging and booming … Continue reading Top RN to BSN Releases 50 Best Online RN to BSN Programs 2017

Drugs score big wins against lung, prostate, breast cancers

CHICAGO/June 5, 2017 (AP)(STL.News) — Drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There’s even a “uni-drug” that may fight many forms of the disease. What’s striking: The drugs are beneficial in some cases for more than a year, much longer than … Continue reading Drugs score big wins against lung, prostate, breast cancers